Cancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical Trials
CANCER GENETICS (CGIX)
Last cancer genetics earnings: 11/19 04:16 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.cancergenetics.com
Company Research
Source: GlobeNewswire
RUTHERFORD, N.J., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced the successful CLIA validation and commercial launch of Thermo Fisher Scientific’s next-generation sequencing (NGS) Oncomine™ Comprehensive Assay v3 for biopharma clinical trials. John A. Roberts, Chief Executive Officer of Cancer Genetics, commented, “As we have previously announced, we are continuing to gain momentum with key channel partners. Oncomine™ Comprehensive Assay v3 provides confidence in understanding cancer mutations. This newest version of the assay supports both translational and clinical researchers with superior tumor profiling capabilities that enable reliable results. We are excited about the potential of the Oncomine Comprehensive Assay in drastically improving clinical oncology research.” Oncomine Comprehensive Assay v3 features content ba
Show less
Read more
Impact Snapshot
Event Time:
CGIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CGIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CGIX alerts
High impacting CANCER GENETICS news events
Weekly update
A roundup of the hottest topics